3-62372201-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_018008.4(FEZF2):​c.668C>T​(p.Ala223Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,576,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

FEZF2
NM_018008.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.97
Variant links:
Genes affected
FEZF2 (HGNC:13506): (FEZ family zinc finger 2) Predicted to enable transcription cis-regulatory region binding activity. Predicted to be involved in positive regulation of transcription, DNA-templated. Predicted to act upstream of or within several processes, including negative regulation of transcription by RNA polymerase II; nervous system development; and regulation of neuron differentiation. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.037337184).
BS2
High AC in GnomAd4 at 24 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FEZF2NM_018008.4 linkuse as main transcriptc.668C>T p.Ala223Val missense_variant 2/5 ENST00000283268.8 NP_060478.3 Q8TBJ5-1A0A140VKG3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FEZF2ENST00000283268.8 linkuse as main transcriptc.668C>T p.Ala223Val missense_variant 2/51 NM_018008.4 ENSP00000283268.3 Q8TBJ5-1
FEZF2ENST00000475839.1 linkuse as main transcriptc.668C>T p.Ala223Val missense_variant 1/41 ENSP00000418804.1 Q8TBJ5-1
FEZF2ENST00000486811.5 linkuse as main transcriptc.668C>T p.Ala223Val missense_variant 3/65 ENSP00000418589.1 Q8TBJ5-1

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
152198
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000240
AC:
44
AN:
183596
Hom.:
0
AF XY:
0.000222
AC XY:
22
AN XY:
99194
show subpopulations
Gnomad AFR exome
AF:
0.000403
Gnomad AMR exome
AF:
0.000508
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000239
Gnomad NFE exome
AF:
0.000221
Gnomad OTH exome
AF:
0.00103
GnomAD4 exome
AF:
0.000197
AC:
281
AN:
1424556
Hom.:
0
Cov.:
32
AF XY:
0.000193
AC XY:
136
AN XY:
705226
show subpopulations
Gnomad4 AFR exome
AF:
0.0000611
Gnomad4 AMR exome
AF:
0.000489
Gnomad4 ASJ exome
AF:
0.0000394
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000489
Gnomad4 FIN exome
AF:
0.000239
Gnomad4 NFE exome
AF:
0.000216
Gnomad4 OTH exome
AF:
0.000119
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
152198
Hom.:
0
Cov.:
33
AF XY:
0.000135
AC XY:
10
AN XY:
74348
show subpopulations
Gnomad4 AFR
AF:
0.000121
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000250
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000174
Hom.:
0
Bravo
AF:
0.000212
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000235
AC:
2
ExAC
AF:
0.000175
AC:
21

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 25, 2022The c.668C>T (p.A223V) alteration is located in exon 2 (coding exon 1) of the FEZF2 gene. This alteration results from a C to T substitution at nucleotide position 668, causing the alanine (A) at amino acid position 223 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Benign
0.20
T;T;T
Eigen
Benign
-0.010
Eigen_PC
Benign
0.061
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.70
.;.;T
M_CAP
Benign
0.0043
T
MetaRNN
Benign
0.037
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.83
L;L;L
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.095
Sift
Benign
0.50
T;T;T
Sift4G
Benign
0.30
T;T;T
Polyphen
0.75
P;P;P
Vest4
0.096
MVP
0.28
MPC
0.52
ClinPred
0.029
T
GERP RS
5.0
Varity_R
0.17
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374025354; hg19: chr3-62357876; COSMIC: COSV99335034; COSMIC: COSV99335034; API